(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Mar 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -10.33%57.06M | -33.92%190.94M | -67.46%63.63M | -21.97%288.96M | --195.53M | 16.32%370.31M | 189.10%102.46M | 1.77%318.35M | --35.44M | 33.72%312.8M |
Operating income | -10.33%57.06M | -33.92%190.94M | -67.46%63.63M | -21.97%288.96M | 195.53M | 16.32%370.31M | 189.10%102.46M | 1.77%318.35M | 35.44M | 33.72%312.8M |
Cost of sales | 10.94%-52.03M | 24.14%-173.35M | 61.47%-58.43M | 20.80%-228.52M | ---151.64M | -16.23%-288.52M | -164.66%-77.77M | -0.48%-248.24M | ---29.39M | -37.57%-247.05M |
Operating expenses | 10.94%-52.03M | 24.14%-173.35M | 61.47%-58.43M | 20.80%-228.52M | -151.64M | -16.23%-288.52M | -164.66%-77.77M | -0.48%-248.24M | -29.39M | -37.57%-247.05M |
Gross profit | -3.36%5.03M | -70.89%17.6M | -88.15%5.2M | -26.10%60.44M | 43.89M | 16.66%81.79M | 307.68%24.69M | 6.63%70.11M | 6.06M | 21.00%65.75M |
Selling expenses | -14.95%-2.51M | 9.79%-8.22M | 52.97%-2.18M | 10.04%-9.11M | ---4.64M | -41.52%-10.12M | -167.32%-2.04M | 12.05%-7.15M | ---762K | -24.95%-8.13M |
Administrative expenses | 17.05%-7.32M | 40.99%-17.68M | 42.40%-8.82M | 7.48%-29.97M | ---15.31M | -106.30%-32.39M | -73.38%-4.29M | 7.57%-15.7M | ---2.47M | -28.98%-16.99M |
Impairment and provision | 35.53%946K | -313.70%-2M | 202.80%698K | 97.05%934K | ---679K | 127.01%474K | -152.34%-682K | 14.01%-1.76M | --1.3M | -274.50%-2.04M |
-Other impairment is provision | 35.53%946K | -313.70%-2M | 202.80%698K | 97.05%934K | ---679K | 127.01%474K | -152.34%-682K | 14.01%-1.76M | --1.3M | -274.50%-2.04M |
Special items of operating profit | 71.51%578K | -6.76%5.36M | 1.81%337K | 177.56%5.75M | --331K | -45.44%2.07M | 445.95%404K | 138.42%3.8M | --74K | -12.04%1.59M |
Operating profit | 31.31%-3.27M | -117.59%-4.93M | -120.20%-4.77M | -32.93%28.05M | 23.59M | -15.17%41.82M | 330.76%18.09M | 22.69%49.3M | 4.2M | 11.84%40.18M |
Financing income | -39.68%611K | 39.02%1.61M | 283.71%1.01M | 8.50%1.16M | --264K | 353.39%1.07M | 1,811.11%172K | 10.28%236K | --9K | 58.52%214K |
Financing cost | ---450K | -157.40%-574K | ---- | 72.97%-223K | ---209K | 29.55%-825K | 27.63%-296K | 13.96%-1.17M | ---409K | -3,219.51%-1.36M |
Earning before tax | 17.06%-3.11M | -113.43%-3.89M | -115.87%-3.75M | -31.09%28.99M | 23.65M | -13.02%42.07M | 372.84%17.97M | 23.90%48.37M | 3.8M | 8.37%39.04M |
Tax | 858.04%849K | 133.04%1.33M | 96.96%-112K | 36.72%-4.04M | ---3.68M | -3.02%-6.38M | -460.05%-2.31M | -30.68%-6.19M | ---413K | -0.94%-4.74M |
After-tax profit from continuing operations | 41.43%-2.26M | -110.26%-2.56M | -119.35%-3.86M | -30.08%24.95M | 19.97M | -15.38%35.69M | 362.21%15.66M | 22.96%42.17M | 3.39M | 9.48%34.3M |
Earning after tax | 41.43%-2.26M | -110.26%-2.56M | -119.35%-3.86M | -30.08%24.95M | 19.97M | -15.38%35.69M | 362.21%15.66M | 22.96%42.17M | 3.39M | 9.48%34.3M |
Profit attributable to shareholders | 41.43%-2.26M | -110.26%-2.56M | -119.35%-3.86M | -30.08%24.95M | 19.97M | -15.38%35.69M | 362.21%15.66M | 22.96%42.17M | 3.39M | 9.48%34.3M |
Basic earnings per share | 40.00%-0.003 | -108.33%-0.003 | -115.15%-0.005 | -38.98%0.036 | 0.033 | -100.00%0.059 | 22.96%42.17K | 34.3K | ||
Diluted earnings per share | 40.00%-0.003 | -108.33%-0.003 | -115.15%-0.005 | -38.98%0.036 | 0.033 | -100.00%0.059 | 22.96%42.17K | 34.3K | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data